Neurones

Neurones OCF/Debt

The Operating Cash Flow to Debt Ratio of Neurones (NRO.PA) as of Nov 3, 2026 is 218.52 %. In the previous year, Operating Cash Flow to Debt Ratio was 200.83 % — a change of 8.81% (higher).

OCF/Debt

218.52 %

YoY

8.81%

Last updated:

Operating Cash Flow to Debt Ratio of Neurones is 2025 218.52 % . Operating Cash Flow to Debt Ratio of Neurones was 2024 200.83 % . It decreases by 8.81% higher compared to the previous year.

The Neurones OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
8,283.20 EUR
Jan 1, 2019
193.85 EUR
Jan 1, 2020
196.87 EUR
Jan 1, 2021
182.60 EUR
Jan 1, 2022
154.54 EUR
Jan 1, 2023
163.87 EUR
Jan 1, 2024
200.83 EUR
Jan 1, 2025
218.52 EUR
The Neurones OCF/Debt history
YEAROCF/DebtYoY
218.52 %+8.81%
200.83 %+22.55%
163.87 %+6.04%
154.54 %-15.37%
182.60 %-7.25%
196.87 %+1.56%
193.85 %-97.66%
8,283.20 %+392.69%
1,681.21 %+114.09%
785.30 %-9.22%
865.05 %-89.05%
7,901.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurones Stock analysis

What does Neurones do? Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurones stock

Operating Cash Flow to Debt Ratio of Neurones is 218.52 % in 2025.

Operating Cash Flow to Debt Ratio of Neurones changed from 200.83 % to 218.52 %, representing a 8.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Neurones since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Neurones with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Neurones

All Key Metrics — Neurones